Misfortune Cookie Flaw Puts 12 Million Routers at Risk

http://recode.net/2014/12/18/misfortune-cookie-flaw-puts-12-million-routers-at-risk/



Misfortune Cookie Flaw Puts 12 Million Routers at Risk














Researchers at the security software company Check Point say they’ve discovered a serious vulnerability lurking inside the routers and modems used to deliver Internet connectivity to 12 million homes and small businesses around the world, and it’s going to be a complicated matter to fix it.

Dubbed the Misfortune Cookie, the weakness is present in cable and DSL modems from well-known manufacturers like D-Link, Huawei and ZTE, and could allow a malicious hacker to hijack them and attack connected computers, phones and tablets. An attacker exploiting Misfortune Cookie could also monitor a vulnerable Internet connection, stealing passwords, business data or other information. Check Point didn’t disclose how an attack might be carried out. Spokespeople for D-Link, Huawei and ZTE had no immediate comment on the vulnerability.

In an interview with Re/code, Shahar Tal, a researcher at Israel-based Check Point, said the company traced the vulnerability to a programming error made in 2002. That error originated with Allegro Software, the Massachusetts-based developer of RomPager, which unwittingly introduced it into the widely used embedded Web server.

“It was a very simple error that seemed benign at first,” Tal said. “When we took it back to the company, they seemed surprised. The severity was not something they expected.”

The list of devices affected by Misfortune Cookie includes some 200 products from more than 20 companies. All told there are more than 12 million devices with the vulnerability in use today, including some that were manufactured as recently as this year. And yet to date, no real-world attacks using Misfortune Cookie have been detected.

Reached for comment, Allegro Software downplayed the severity of the vulnerability and its responsibility for it. “It’s a 12-year-old bug that was fixed nine years ago,” said CEO Bob Van Andel. He conceded, however, that many of Allegro’s customers haven’t bothered to install the code that protects RomPager against Misfortune Cookie — nor can the company force them to do so.

“There is no contractual obligation on the part of our customers to use the latest code,” Van Andel said. “We have more than 300 customers. Some of them keep up on the maintenance of the code we sell them, but the vast majority do not. They run their own insurance risk when they make that decision.”

So what’s to be done if you suspect your router or modem is among those affected by Misfortune Cookie? Tal suggests calling the manufacturer or the company that provided the equipment and requesting an upgrade.

A Message From Universal Pictures About Angelina Jolie

The TPP is the dirtiest deal you've never heard of.

Food Recall Warning - Your Fresh Market brand ground beef products recalled due to E. coli O157

Food Recall Warning - Your Fresh Market brand ground beef products recalled due to E. coli O157


Recall date:


December 1, 2014
Reason for recall:


Microbiological - E. coli O157
Hazard classification:


Class 1
Company / Firm:


Cargill Meat Solutions (Est. 700)
Distribution:


Alberta, British Columbia, Manitoba, Saskatchewan
Extent of the distribution:


Consumer
Reference number:


9497












Recall details


Ottawa, December 1, 2014 - Cargill Meat Solutions (Est. 700) is recalling Your Fresh Market brand ground beef products from the marketplace due to possible E. coli O157 contamination. Consumers should not consume the recalled products described below.


The following products have been sold at Walmart stores in Alberta, British Columbia, Manitoba and Saskatchewan.






Recalled products



Brand Name

Common Name

Size

Code(s) on Product

UPC


Your Fresh Market

Extra Lean Ground Beef Sirloin

475 g

Best Before 2014.NO.28

6 05388 18363 7


Your Fresh Market

Extra Lean Ground Beef

475 g

Best Before 2014.NO.28

6 05388 18369 9


Your Fresh Market

Medium Ground Beef

475 g

Best Before 2014.NO.28

6 05388 18365 1


Your Fresh Market

Lean Ground Beef

475 g

Best Before 2014.NO.28 and 2014.NO.29

6 05388 18376 7


Your Fresh Market

Extra Lean Ground Beef

900 g

Best Before 2014.NO.28

6 05388 18372 9


Your Fresh Market

Lean Ground Beef

900 g

Best Before 2014.NO.28

6 05388 18378 1


Your Fresh Market

Lean Ground Beef

1.6 kg

Best Before 2014.NO.28 and 2014.NO.29

6 05388 18379 8







What you should do


Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.


Food contaminated with E. coli O157 may not look or smell spoiled but can still make you sick. Symptoms can include nausea, vomiting, mild to severe abdominal cramps and watery to bloody diarrhea. In severe cases of illness, some people may have seizures or strokes, need blood transfusions and kidney dialysis or live with permanent kidney damage. In severe cases of illness, people may die.
Learn more about the health risks
Sign up for recall notifications by email or follow us on Twitter
View our detailed explanation of the food safety investigation and recall process






Background


This recall was triggered by test results. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.


The CFIA is verifying that industry is removing recalled product from the marketplace.






Illnesses


There have been no reported illnesses associated with the consumption of these products.











Printer ready version of photos

• 
• 
• 
• 
• 
• 
• 

Ezra Levant loses libel case, must pay $80,000 to man he defamed as ‘illiberal Islamic fascist’

Ezra Levant loses libel case, must pay $80,000 to man he defamed as ‘illiberal Islamic fascist’

Historic $130 million gift from the Rogers family to establish the Ted Rogers Centre for Heart Research Peter Munk Cardiac Centre

Historic $130 million gift from the Rogers family to establish the Ted Rogers Centre for Heart Research



Largest private donation in Canadian health care history will bring together the strengths of SickKids, UHN, and U of T
in individualized genomic medicine, tissue engineering, and advanced cardiac care.

Goal to reduce hospitalization for heart failure by 50 per cent in 10 years.

The Rogers family gift to be matched with an additional $139 million from partner organizations
for a total investment of $269 million.

TORONTO, November 20, 2014 – The Hospital for Sick Children (SickKids), University Health Network (UHN) and the University of Toronto (U of T) announced today the creation of the Ted Rogers Centre for Heart Research (the Centre) funded by an unprecedented donation of $130 million from the Rogers family – the largest monetary gift ever made to a Canadian health care initiative. The donation will be matched with $139 million in additional funds combined from SickKids, UHN, and U of T for a total investment of $269 million.

“We’re thrilled to be able to bring the Ted Rogers Centre for Heart Research to life,” said Loretta Rogers, wife of the late Ted Rogers. “It’s a testament to Ted’s drive for innovation and his commitment to leaving the world a better place. We know Ted would have been proud of this bold initiative that will improve heart health for all.”

Ted Rogers’ personal experience with heart disease and his interest in finding new therapies to advance heart health make the Ted Rogers Centre for Heart Research a fitting legacy, noted Dr. Michael Apkon, President and CEO of SickKids. “The generosity and magnitude of this gift, and the transformational effect it will have on heart research, truly reflects the pioneering and innovative spirit of Ted Rogers and his family. This powerful, collaborative partnership among SickKids, UHN and U of T will have a global impact. Together we hope to accelerate discovery and cardiac care at an unprecedented pace.”

Heart disease represents a considerable economic strain on the Canadian health care system. The annual cost for managing moderate and severe heart failure patients in Canada is as much as $2.3 billion. “Today, one million Canadians are living with heart failure, and that number is projected to increase 25 per cent over the next 20 years,” noted Dr. Barry Rubin, Chair and Program Medical Director of UHN’s Peter Munk Cardiac Centre. “This unprecedented gift will enable physicians and scientists working together in the Ted Rogers Centre for Heart Research to develop new therapies that will dramatically improve the lives of patients with heart disease. One of our primary goals is to reduce hospitalization for heart failure by 50 per cent in the next decade. Ted Rogers led the development of the telecommunications industry through a constant focus on innovation. We will use Mr. Rogers’ approach to change the face of heart disease in Canada and throughout the world.”

Adding to the exceptional nexus of clinicians, scientists and engineers already accelerating the pace of change in cardiac care across the partner institutions, The Centre will be a magnet to attract the top research talent from around the world, further solidifying Toronto and Canada’s position as global leaders in cardiac care, noted Professor Meric Gertler, President of the University of Toronto. “The Toronto region is home to one of the world’s largest biomedical science and health education clusters. This exceptionally powerful network of researchers and educators is translating exciting ideas, innovations and therapies in stem cell research and regenerative medicine into clinical settings where they will address the most challenging problems across the spectrum of heart disease. With its pioneering spirit and innovative approach, the Ted Rogers Centre for Heart Research will be a world-class collaboration and a most fitting tribute to its namesake.”

The Centre will have facilities in the three participating institutions, with its directorate situated at UHN. It will be the first in the world to bring together research, education and innovation in individualized genomic medicine, stem cell research, bioengineering, and cardiovascular treatment and management under one umbrella with a single focus: improving heart health across the entire life span, from children to adults. Each partner will take the lead in a particular area of focus:
SickKids will harness the power of genomic science to decode the genetic foundations of cardiac disease, which will allow for heart disease to be better predicted before it occurs, and will support individualized therapies for children and adults, based on the unique genome of each patient.
UHN, through the application of powerful databases, new biomarkers for cardiac disease, regenerative and individualized medicine approaches and state-of-the-art-real-time home monitoring and telecommunications technologies, will focus on the translation of research discovery into the delivery of care for patients. Foundational to this approach is a customized cardiovascular data module for a new electronic patient record which is linked to a Biobank which will house a vast array of biologic samples that come from both adult and paediatric patients.
U of T will combine stem cell technology with novel approaches in cellular and tissue engineering for the regeneration of heart muscle, coronary vessels, and heart valves; enlarge our understanding of how genetic, molecular signaling, and cellular networks function as the heart develops, opening up the possibility for more effective heart therapies; and, create technologies and tools for improved heart physiology monitoring in clinical settings.

The Centre will also establish an innovation fund to drive discovery and development of next-generation therapies for heart failure, and an education fund to attract the best and brightest students and postgraduates to ensure a deep pool of talent in Canada for cardiac care and research.

To learn more about the Ted Rogers Centre for Heart Research, go to www.TedRogersResearch.ca

Historic $130-million gift to establish the Ted Rogers Centre for Heart Research Largest private donation in Canadian health-care history will bring together the strengths of SickKids, UHN and U of T in personalized genomic medicine, tissue engineering, and advanced cardiac care to address heart failure across the lifespan University of Toronto.

Historic $130-million gift to establish the Ted Rogers Centre for Heart Research


Largest private donation in Canadian health-care history will bring together the strengths of SickKids, UHN and U of T in personalized genomic medicine, tissue engineering, and advanced cardiac care to address heart failure across the lifespan





“We’re thrilled to be able to bring the Ted Rogers Centre for Heart Research to life,” said Loretta Rogers, wife of the late Ted Rogers. “We know Ted would have been proud of this bold initiative that will improve heart health for all.”With the goal to reduce hospitalization for heart failure by 50 per cent over the next decade, the Hospital for Sick Children, the University Health Network and the University of Toronto have announced the creation of the Ted Rogers Centre for Heart Research, funded by an unprecedented donation of $130 million from the Rogers family – the largest monetary gift ever made to a Canadian health-care initiative.


“The generosity and magnitude of this gift and the transformational effect it will have on heart research truly reflects the pioneering and innovative spirit of Ted Rogers and his family,” said Dr. Michael Apkon, president and chief executive officer of SickKids. “This powerful, collaborative partnership among SickKids, UHN and U of T will have a global impact. Together we hope to accelerate discovery and cardiac care at an unprecedented pace.”


Heart disease represents a considerable economic strain on the Canadian health-care system. The annual cost for managing moderate and severe heart failure patients in Canada is as much as $2.3 billion.


“Today, one million Canadians are living with heart failure, and that number is projected to increase 25 per cent over the next 20 years,” said Dr. Barry Rubin, chair and program medical director of the Peter Munk Cardiac Centre and a professor of surgery at U of T. “This unprecedented gift will enable research teams in the Ted Rogers Centre for Heart Research to develop new therapies that will dramatically improve the lives of patients with heart disease.”


The Ted Rogers Centre for Heart Research will bring together more than 30 expert clinicians and researchers from across the partner institutions, as well as up to 80 graduate students, postdoctoral fellows and clinical fellows who represent the future of the field. This critical mass of expertise will improve treatments for heart patients – and develop entirely new therapies. The Ted Rogers Centre for Heart Research will be a magnet to attract additional research talent from around the world, solidifying Toronto’s and Canada’s position as a global leader in cardiac care, said Professor Meric Gertler, president of U of T.


“The Toronto region is home to one of the world’s largest biomedical science and health education clusters,” said Gertler. “This exceptionally powerful network of researchers and educators is translating exciting ideas, innovations and therapies in stem cell research and regenerative medicine into clinical settings where they will address the most challenging problems across the spectrum of heart disease.


“With its pioneering spirit and innovative approach, the Ted Rogers Centre for Heart Research will be a world-class collaboration and a most fitting tribute to its namesake.”








The Ted Rogers Centre for Heart Research will have facilities in each of the three participating institutions. It will be the first in the world to bring together research, education and innovation in personalized genomic medicine, stem cell research, bioengineering, and cardiovascular treatment and management under one umbrella with a single focus: improving heart health across the entire lifespan, from children to adults.


Each institutional partner will take the lead in a particular area:
SickKids will harness the power of genomic science to decode the genetic foundations of cardiac disease, which will allow for heart disease to be better predicted before it occurs, and will support individualized therapies for children and adults, based on the unique genome of each patient.
UHN, through the application of powerful databases, new biomarkers for cardiac disease, regenerative and individualized medicine approaches and state-of-the-art-real-time home monitoring and telecommunications technologies, will focus on the translation of research discovery into the delivery of care for patients. Foundational to this approach is a customized cardiovascular data module for a new electronic patient record which is linked to a Biobank which will house a vast array of biologic samples that come from both adult and paediatric patients.
U of T will focus on combining stem cell technology with novel approaches in cellular and tissue engineering for the regeneration of heart muscle, coronary vessels and heart valves. This cutting-edge science, which is crucial to restoring damaged hearts, will be led out of U of T’s Institute of Biomaterials and Biomedical Engineering, one of the many fields in which the university is recognized as a world leader.


Professor Peter Zandstra, a lead U of T investigator for the Ted Rogers Centre for Heart Research, says patients with valve disorders, for example, typically need several complex operations during their lifetime to implant larger valves to accommodate the growing heart. They also require drugs to keep their heart from rejecting valve replacements.


“Research at the centre could one day lead to the regeneration of a valve with the patient’s own cells – eliminating a lifetime of chronic illness,” he said.


Cardiac fibrosis is a stiffening of the heart tissue that leads to a variety of cardiac diseases, including heart failure. Zandstra says advances in tissue engineering at U of T will accelerate the discovery of biomaterials that could be used to treat fibrosis, bringing new hope to patients.


Research at the University will also enlarge our understanding of how genetic, molecular signalling and cellular networks function as the heart develops, opening up the possibility for more effective heart therapies.


The establishment of the new centre will enable U of T scientists to create technologies and tools for improved heart physiology monitoring, in clinical settings and for patients at home. These efforts will lead to more seamless, integrated care for heart patients.


The Ted Rogers Centre for Heart Research will also establish a competitive innovation fund to drive discovery and development of next-generation therapies for heart failure, and an education fund to attract the best and brightest students and postgraduates to ensure a deep pool of talent in Canada for cardiac care and research.


Over the next decade, the Ted Rogers Centre for Heart Research will help enable more people – adults and children alike, in Canada and around the world – to live long, healthy and happy lives.